تجاوز إلى المحتوى الرئيسي
Safety-Related Labeling Changes
Hyperprolactinaemia associated with Selective serotonin reuptake inhibitor (SSRIs)/ Serotonin and norepinephrine reuptake inhibitors (SNRIs)
Trade Name
Entapro
Updated Section
4.8 Undesirable effects
Month
Aug,2023